Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan, China.
J Diabetes. 2024 Nov;16(11):e70033. doi: 10.1111/1753-0407.70033.
BACKGROUND: Intensive glycemic control is insufficient to reduce the risk of heart failure in patients with diabetes mellitus. While the hyperglycemic memory in the diabetic cardiomyopathy has been well documented, its underlying mechanisms are not fully understood. The present study tried to investigate whether the dysregulated proteins/biological pathways, which persistently altered in diabetic hearts during normoglycemia, participate in the hyperglycemic memory. METHODS: Hearts of streptozotocin-induced diabetic mice, with or without intensive glycemic control using slow-release insulin implants, were collected. Proteins from total heart samples and subcellular fractions were assessed by mass spectrometry, Western blotting, and KEGG pathway enrichment analysis. mRNA sequencing was used to determine whether the persistently altered proteins were regulated at the transcriptional or post-transcriptional level. RESULTS: Western blot validation of several proteins with high pathophysiological importance, including MYH7, HMGCS2, PDK4, and BDH1, indicated that mass spectrometry was able to qualitatively, but not quantitatively, reflect the fold changes of certain proteins in diabetes. Pathway analysis revealed that the peroxisome, PPAR pathway, and fatty acid metabolism could be efficiently rescued by glycemic control. However, dysregulation of oxidative phosphorylation and reactive oxygen species persisted even after normalization of hyperglycemia. Notably, mRNA sequencing revealed that dysregulated proteins in the oxidative phosphorylation pathway were not accompanied by coordinated changes in mRNA levels, indicating post-transcriptional regulation. Moreover, literature review and bioinformatics analysis suggested that hyperglycemia-induced persistent alterations of miRNAs targeted genes from the persistently dysregulated oxidative phosphorylation pathway, whereas, oxidative phosphorylation dysfunction-induced ROS regulated miRNA expression, which thereby might sustained the dysregulation of miRNAs. CONCLUSIONS: Glycemic control cannot rescue hyperglycemia-induced alterations of subcellular proteins in the diabetic heart, and persistently altered proteins are involved in multiple functional pathways, including oxidative phosphorylation. These findings might provide novel insights into hyperglycemic memory in diabetic cardiomyopathy.
背景:强化血糖控制不足以降低糖尿病患者心力衰竭的风险。虽然糖尿病心肌病中的高血糖记忆已经得到充分证实,但其潜在机制尚不完全清楚。本研究试图探讨在正常血糖下,持续改变糖尿病心脏的失调蛋白/生物学途径是否参与高血糖记忆。
方法:收集链脲佐菌素诱导的糖尿病小鼠的心脏,并用或不用缓释胰岛素植入进行强化血糖控制。通过质谱、Western blot 和 KEGG 途径富集分析评估总心脏样本和亚细胞部分的蛋白质。mRNA 测序用于确定持续改变的蛋白质是否在转录或转录后水平受到调节。
结果:对几种具有高病理生理重要性的蛋白质(包括 MYH7、HMGCS2、PDK4 和 BDH1)进行 Western blot 验证,表明质谱能够定性但不能定量反映糖尿病中某些蛋白质的变化倍数。途径分析表明,过氧化物酶体、PPAR 途径和脂肪酸代谢可以通过血糖控制得到有效挽救。然而,即使在高血糖正常化后,氧化磷酸化和活性氧的失调仍然存在。值得注意的是,mRNA 测序显示,氧化磷酸化途径失调的蛋白质并不伴有 mRNA 水平的协调变化,表明存在转录后调节。此外,文献综述和生物信息学分析表明,高血糖诱导的 miRNA 靶向基因的持续改变与氧化磷酸化途径的持续失调有关,而氧化磷酸化功能障碍诱导的 ROS 调节 miRNA 表达,从而可能维持 miRNA 的失调。
结论:血糖控制不能挽救糖尿病心脏中高血糖诱导的亚细胞蛋白质的改变,持续改变的蛋白质参与多个功能途径,包括氧化磷酸化。这些发现可能为糖尿病心肌病中的高血糖记忆提供新的见解。
Eur Heart J. 2015-11-9
Cell Physiol Biochem. 2018
Front Med. 2022-2
Circ Res. 2020-10-23
Am J Physiol Cell Physiol. 2014-6-11
Int J Mol Sci. 2022-1-26
Mol Ther Nucleic Acids. 2022-12-14
J Clin Med. 2022-3-8
Front Med. 2022-2
Cardiovasc Diabetol. 2021-1-4
Aging (Albany NY). 2020-11-7